Published in Hepatitis Weekly, October 30th, 2000
Researchers reported this finding in the Journal of Hepatology ("Combined treatment of relapse of chronic hepatitis C with high-dose a(2)b interferon plus ribavirin for 6 or 12 months," J Hepatol, 2000;33(3):456-462).
Fifty HCV patients considered to be relapsers of alpha-interferon (IFN) therapy were chosen to participate in a trial where they were given additional doses of combination...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.